Which hedge funds own HIMS? HIMS & HERS HEALTH INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
10 of the hedge funds tracked by WhaleCreep disclosed a position in HIMS (HIMS & HERS HEALTH INC) in their Q2 2026 13F filings, worth $258.6m in total. The largest holder by portfolio weight is Casdin Capital at 1.2% of its book. 2 managers opened a new position this quarter: Baillie Gifford, Tudor Investment. 5 exited: Ancora Advisors, Avidity Partners, Farallon Capital Management.
10tracked managers holding
2opened this quarter
5exited this quarter
Which hedge funds hold HIMS? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Casdin Capital | Q2 2026 | 1.2% | $24.3m | 700,000 | 0% | held |
| Marshall Wace | Q2 2026 | 0.1% | $146.2m | 4,217,767 | 482% | added |
| Davidson Kempner Capital Management | Q2 2026 | 0.1% | $5.5m | 160,012 | 0% | held |
| Baillie Gifford | Q2 2026 | 0.0% | $39.9m | 750,491 | – | new |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $1.3m | 38,148 | 110% | added |
| Tudor Investment | Q2 2026 | 0.0% | $4.5m | 128,796 | – | new |
| Citadel Advisors | Q2 2026 | 0.0% | $29.4m | 846,936 | 22% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $5.9m | 171,530 | -71% | reduced |
| Holocene Advisors | Q2 2026 | 0.0% | $1.4m | 38,962 | -93% | reduced |
| Bridgewater Associates | Q2 2026 | 0.0% | $243.9k | 7,036 | -83% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Ancora Advisors | 0.0% | $208 |
| Avidity Partners | 6.0% | $1.6m |
| Farallon Capital Management | 0.0% | $207.6k |
| Renaissance Technologies LLC | 0.8% | $44.0m |
| Woodline Partners | 0.1% | $3.2m |
How has hedge fund ownership of HIMS changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 10 | $258.6m |
| Q1 2026 | 14 | $125.4m |
| Q4 2025 | 5 | $279.1m |
| Q3 2025 | 8 | $1.2bn |
| Q2 2025 | 7 | $1.0bn |
| Q1 2025 | 6 | $600.1m |
| Q4 2024 | 5 | $376.9m |
| Q3 2024 | 4 | $106.7m |
| Q2 2024 | 4 | $145.4m |
| Q1 2024 | 4 | $78.9m |
| Q4 2023 | 2 | $6.2m |
| Q3 2023 | 2 | $8.7m |
| Q2 2023 | 2 | $16.4m |
| Q1 2023 | 4 | $19.9m |
| Q4 2022 | 1 | $9.7m |
| Q3 2022 | 3 | $10.6m |
Counts every tracked manager that disclosed HIMS in that quarter's filing, including managers that have since stopped filing.